Get Started

SGHT

NASD Sight Sciences, Inc.
Oct 25, 2026 · 8:19 PM ET EOD Market Closed

$8.99 ↑ +0.00 (+0.00%) Trading Up from the previous close of $8.99, $0.27 below the day’s high of $9.26

YTD change
+13.37%
vs 20-day SMA
+2.66%
vs 200-day SMA
+51.71%

Price ranges

Previous day
$8.74 $9.26
open $9.08 close $8.99
-$0.09 (-0.99%)
Today
$8.74 $9.26
$8.99
Past week
$8.09 $9.10
from $8.80 now $8.99
+$0.19 (+2.16%)
Past month
$7.84 $9.71
from $8.68 now $8.99
+$0.31 (+3.57%)
This year
$3.38 $9.71
from $7.93 now $8.99
+$1.06 (+13.37%)

Price & Performance

+4.67 (+108.10%) / 6M

$3.54$5.62$7.71$9.79Apr 27Jul 27Oct 23

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 78.9% away from all-time highs of $42.57
  • SGHT is up 13% since the beginning of the year
  • SGHT is up 73% over the past 12 months
  • SGHT is up 4% over the past 1 month
  • 4% of all SGHT investors are betting against SGHT

SGHT reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +73.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.08
Earnings momentum +35.1% Quarterly EPS growth
Quarterly change +35.1%

Valuation

P/E ratio N/A
Enterprise value $457.7M
Beta 3.68

Balance sheet & scale

IncomeN/A
Revenue$83.4M
Cash$79.8M
Debt$42.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $495.3M

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $33.64 -1.38%
BDX Becton, Dickinson and Company $198.91 -0.75%
MDLN Medline, Inc. Class A $34.09 -2.26%
DXCM DexCom, Inc. $77.94 -0.49%
WST West Pharmaceutical Services, Inc. $392.15 -0.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.